Sarah Cannon Research Institute is a research organization focusing on therapies for patients including drug development. With corporate headquarters in Nashville, Tennessee, United States, it conducts community-based clinical trials in oncology, cardiology, gastroenterology, and other therapeutic areas. The current CEO is Dee Anna Smith.